| Elizabeth Levine, CCC-SLP | |
|
701 Prairie Hawk Dr, Castle Rock, CO 80109-8001 | |
| (419) 944-8986 | |
| Not Available |
| Full Name | Elizabeth Levine |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 701 Prairie Hawk Dr, Castle Rock, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093913659 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 16112 (California) | Secondary |
| 235Z00000X | Speech-language Pathologist | SLP.0002151 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth Levine, CCC-SLP 701 Prairie Hawk Dr, Castle Rock, CO 80109-8001 Ph: () - | Elizabeth Levine, CCC-SLP 701 Prairie Hawk Dr, Castle Rock, CO 80109-8001 Ph: (419) 944-8986 |
News Archive
According to the American Heart Association the new simpler guidelines for giving CPR to people suffering cardiac arrest, will be more effective in keeping the blood flowing to the heart, when people suffer a heart attack.
Researchers from Jefferson's Kimmel Cancer Center have genetic evidence suggesting the antioxidant drugs currently used to treat lung disease, malaria and even the common cold can also help prevent and treat cancers because they fight against mitochondrial oxidative stress-a culprit in driving tumor growth.
A newly-unveiled discovery, which has been four years in the making, has the potential to change the way we look at autoimmune diseases and understand how and why immune cells begin to attack different tissues in the body.
Published today in the New England Journal of Medicine, a phase III clinical trial of Abraxane (paclitaxel formulated as albumin-bound nanoparticles) in combination with gemcitabine in treatment-naive patients with metastatic pancreatic cancer demonstrated a statistically significant improvement in overall survival compared to patients receiving gemcitabine alone [(median of 8.5 vs. 6.7 months) (HR 0.72, P=0.000015)].
› Verified 1 days ago
Mrs. Melissa Walker, MSP, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2622 Mclean Ct, Castle Rock, CO 80109 Phone: 720-271-1974 | |
Speech Therapy Co Llc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2661 Castle Crest Dr, Castle Rock, CO 80104 Phone: 818-314-4273 | |
Noelle Karen Iorio, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 620 Wilcox St, Castle Rock, CO 80104 Phone: 303-387-0100 | |
Mrs. Jennifer Jackson, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1105 Mcmurdo Cir, Castle Rock, CO 80108 Phone: 720-308-4543 | |
Nicole Belanger, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 701 Prairie Hawk Dr, Castle Rock, CO 80109 Phone: 303-387-0100 | |
Janet Tenbarge, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2661 Mashie Cir, Castle Rock, CO 80109 Phone: 303-246-6489 | |
Caitlin Croasdell, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 620 Wilcox St, Castle Rock, CO 80104 Phone: 303-387-0100 |